Gleason Score News and Research

RSS
International, four-year study finds dutasteride reduces risk of prostate cancer diagnosis in men

International, four-year study finds dutasteride reduces risk of prostate cancer diagnosis in men

RCOG prostate cancer treatment database reaches new milestone

RCOG prostate cancer treatment database reaches new milestone

Watchful waiting is viable option for many men with low risk prostate cancer

Watchful waiting is viable option for many men with low risk prostate cancer

DiagnoCure: Global studies confirm clinical utility of PROGENSA PCA3 test

DiagnoCure: Global studies confirm clinical utility of PROGENSA PCA3 test

Study suggests routine evaluation does not predict prostate cancer

Study suggests routine evaluation does not predict prostate cancer

Lower total cholesterol may be caused by undiagnosed cancer: Study

Lower total cholesterol may be caused by undiagnosed cancer: Study

Men with lower cholesterol less likely to develop high-grade prostate cancer

Men with lower cholesterol less likely to develop high-grade prostate cancer

Blood vessels good indicators of prostate cancer behavior

Blood vessels good indicators of prostate cancer behavior

New prostate cancer metastasis prediction method

New prostate cancer metastasis prediction method

Research offers insight into why some prostate cancer returns

Research offers insight into why some prostate cancer returns

Low oxygen levels in prostate tumors can predict recurrence

Low oxygen levels in prostate tumors can predict recurrence

Statins can lower PSA levels in men with prostate cancer

Statins can lower PSA levels in men with prostate cancer

AUA counters mainstream recommendations with new best practice statement on PSA testing

AUA counters mainstream recommendations with new best practice statement on PSA testing

Pomegranate juice may slow the progression of post-treatment prostate cancer recurrence

Pomegranate juice may slow the progression of post-treatment prostate cancer recurrence

Active surveillance can offer prostate cancer patients more individualized patient care

Active surveillance can offer prostate cancer patients more individualized patient care

Selected men with low-risk prostate cancer have good clinical outcomes without immediate treatment

Selected men with low-risk prostate cancer have good clinical outcomes without immediate treatment

Male lumpectomy - first line treatment for prostate cancer

Male lumpectomy - first line treatment for prostate cancer

USA's largest ever prostate cancer screening program shows high compliance and consistent results

USA's largest ever prostate cancer screening program shows high compliance and consistent results

Prostate cancer screening programme shows high compliance and consistent results in more than 38,000 men

Prostate cancer screening programme shows high compliance and consistent results in more than 38,000 men

Seven elevated biomarkers predict prostate cancer risk with 86.6 percent reliability

Seven elevated biomarkers predict prostate cancer risk with 86.6 percent reliability